載入...
Metastatic melanoma: prognostic factors and survival in patients with brain metastases
Brain metastases from malignant melanoma carry a poor prognosis. Novel systemic agents have improved overall survival (OS), but the value of whole-brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) remains uncertain. The melanoma-specific graded prognostic assessment (msGPA) provides usef...
Na minha lista:
| 發表在: | J Neurooncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700221/ https://ncbi.nlm.nih.gov/pubmed/28819707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-017-2591-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|